Bone Mineral Content of the Third Lumbar Vertebra During 18 Months of Prednisolone Treatment for Giant Cell Arteritis

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 1993 Dec 1

PMID 8124904

Citations 3

Authors

E Nordborg

T Hansson

R Jonson

J Szucs

B A Bengtsson

Affiliations

Soon will be listed here.

Abstract

Altogether forty-four patients with giant cell arteritis (GCA) were randomly allocated to either daily morning or alternate-day administration of prednisolone. The BMC of the third lumbar vertebra was determined using dual photon absorptiometry. At least ten measurements were performed in each patient during a period of 18 months. During the course of treatment there was no significant change of the mean BMC in either group compared to the pre-treatment value. The changes of BMC were independent of such potentially explanatory variables as cumulative dose of prednisolone, initial BMC, sex and body weight. Corticosteroid treatment in patients with GCA, in the doses used by us, does not appear to cause excessive bone loss.

Citing Articles

Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis.

Feng Z, Zeng S, Wang Y, Zheng Z, Chen Z PLoS One. 2013; 8(12):e80890.

PMID: 24324644 PMC: 3855695. DOI: 10.1371/journal.pone.0080890.

Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease.

Dunn C, Goa K Drugs. 2001; 61(5):685-712.

PMID: 11368289 DOI: 10.2165/00003495-200161050-00013.

Giant cell arteritis. Epidemiology and treatment.

Nordborg E, Andersson R, Bengtsson B Drugs Aging. 1994; 4(2):135-44.

PMID: 8186541 DOI: 10.2165/00002512-199404020-00006.

References

Roos B . Dual photon absorptiometry in lumbar vertebrae. II. Precision and reproducibility. Acta Radiol Ther Phys Biol. 1975; 14(3):291-303. DOI: 10.3109/02841867509132668. View

Greenberger P, Hendrix R, Patterson R, Chmiel J . Bone studies in patients on prolonged systemic corticosteroid therapy for asthma. Clin Allergy. 1982; 12(4):363-8. DOI: 10.1111/j.1365-2222.1982.tb02540.x. View

de Deuxchaisnes C, Devogelaer J, Esselinckx W, Bouchez B, Depresseux G, Huaux J . The effect of low dosage glucocorticoids on bone mass in rheumatoid arthritis: a cross-sectional and a longitudinal study using single photon absorptiometry. Adv Exp Med Biol. 1984; 171:209-39. View

Ringe J, KUHLENCORDT F, Kruse H . Proceedings: Bone mineral determinations on long-term diabetics. AJR Am J Roentgenol. 1976; 126(6):1300-1. DOI: 10.2214/ajr.126.6.1300. View

Bengtsson B, Malmvall B . The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum. 1981; 24(7):899-904. DOI: 10.1002/art.1780240706. View

Reid D, Nicoll J, Smith M, Higgins B, Tothill P, Nuki G . Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed). 1986; 293(6560):1463-6. PMC: 1342237. DOI: 10.1136/bmj.293.6560.1463. View

Granhed H, Jonson R, Hansson T . Mineral content and strength of lumbar vertebrae. A cadaver study. Acta Orthop Scand. 1989; 60(1):105-9. DOI: 10.3109/17453678909150105. View

Roos B, SKOLDBORN H . Dual photon absorptiometry in lumbar vertebrae. I. Theory and method. Acta Radiol Ther Phys Biol. 1974; 13(3):266-80. DOI: 10.3109/02841867409129883. View

Gluck O, Murphy W, Hahn T, Hahn B . Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy. Arthritis Rheum. 1981; 24(7):892-8. DOI: 10.1002/art.1780240705. View

10.

Rickers H, Deding A, Christiansen C, RODBRO P . Mineral loss in cortical and trabecular bone during high-dose prednisone treatment. Calcif Tissue Int. 1984; 36(3):269-73. DOI: 10.1007/BF02405329. View

11.

Verstraeten A, Dequeker J . Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis. 1986; 45(10):852-7. PMC: 1002008. DOI: 10.1136/ard.45.10.852. View

12.

Schaadt O, Bohr H . Bone mineral in lumbar spine, femoral neck and femoral shaft measured by dual photon absorptiometry with 153-gadolineum in prednisone treatment. Adv Exp Med Biol. 1984; 171:201-8. View

13.

Hahn T . Corticosteroid-induced osteopenia. Arch Intern Med. 1978; 138 Spec No:882-5. View

14.

Andersson R, Rundgren A, Rosengren K, Bengtsson B, Malmvall B, Mellstrom D . Osteoporosis after long-term corticosteroid treatment of giant cell arteritis. J Intern Med. 1990; 227(6):391-5. DOI: 10.1111/j.1365-2796.1990.tb00177.x. View

15.

Nordborg E, Bengtsson B . Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ. 1989; 299(6698):549-50. PMC: 1837376. DOI: 10.1136/bmj.299.6698.549. View

16.

Hansson T, Roos B, Nachemson A . Development of osteopenia in the fourth lumbar vertebra during prolonged bed rest after operation for scoliosis. Acta Orthop Scand. 1975; 46(4):621-30. DOI: 10.3109/17453677508989244. View

17.

Hansson T, Roos B . Age changes in the bone mineral of the lumbar spine in normal women. Calcif Tissue Int. 1986; 38(5):249-51. DOI: 10.1007/BF02556602. View

18.

Adinoff A, Hollister J . Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med. 1983; 309(5):265-8. DOI: 10.1056/NEJM198308043090502. View

19.

Als O, Gotfredsen A, Christiansen C . The effect of glucocorticoids on bone mass in rheumatoid arthritis patients. Influence of menopausal state. Arthritis Rheum. 1985; 28(4):369-75. DOI: 10.1002/art.1780280403. View

20.

Riggs B, Wahner H, Dunn W, Mazess R, Offord K, Melton 3rd L . Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest. 1981; 67(2):328-35. PMC: 370572. DOI: 10.1172/JCI110039. View